RAB4A and cancer: The changes in APPL1 (3p21), RAB5A (3p24) and EEA1 (12q22) and RAB4A (1q42) in PIN or primary cancer tissue compared to their expression in non-malignant tissue may discriminate metastatic tissue and provide an avenue for monitoring disease progression.